<?xml version="1.0" encoding="UTF-8"?>
<metadata
  xmlns="http://example.org/myapp/"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://example.org/myapp/ http://example.org/myapp/schema.xsd"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:dcterms="http://purl.org/dc/terms/"><dc:Title>Antitargets and drug safety / edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz. [electronic resource]</dc:Title>
<dc:Creator>Urbán, László.</dc:Creator>
<dc:Creator>Patel, Vinod F.</dc:Creator>
<dc:Creator>Vaz, Roy J.</dc:Creator>
<dc:Subject>Drug development.</dc:Subject>
<dc:Subject>Drugs Design.</dc:Subject>
<dc:Subject>Drugs Side effects.</dc:Subject>
<dc:Subject>Drug interactions.</dc:Subject>
<dc:Subject>RS420</dc:Subject>
<dc:Subject>615.19 23</dc:Subject>
<dc:Description>Includes bibliographical references and index.</dc:Description>
<dc:Description>Print version record.</dc:Description>
<dc:Description>With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing.</dc:Description>
<dc:Publisher>Weinheim : Wiley-VCH,</dc:Publisher>
<dc:Date>2015.</dc:Date>
<dc:Date>2015.</dc:Date>
<dc:Date>2015</dc:Date>
<dc:Type>Text</dc:Type>
<dc:Format>1 online resource (1266 pages).</dc:Format>
<dc:Identifier>http://onlinelibrary.wiley.com/book/10.1002/9783527673643</dc:Identifier>
<dc:Language>eng</dc:Language>
<dc:Relation>Methods and principles in medicinal chemistry ; v. 66</dc:Relation>
<dc:Relation>Methods and principles in medicinal chemistry ; v. 66.</dc:Relation>
<dc:Relation>Antitargets and Drug Safety.</dc:Relation>
<dc:Relation>Antitargets and Drug Safety.</dc:Relation>

</metadata>